IL6 and acute respiratory distress syndrome: The results of Tang et al. [149] suggest that amygdalin treatment dramatically inhibited TNF-α, IL-6, and IL-1β production, as well as LPS/D-galactosamine (GalN)-induced iNOS and COX-2 protein expression in mice, thus ameliorating acute liver damage (ALI).